Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexaria Bioscience (LEXX) Goodwill & Intangibles (2016 - 2025)

Historic Goodwill & Intangibles for Lexaria Bioscience (LEXX) over the last 11 years, with Q4 2025 value amounting to $308060.0.

  • Lexaria Bioscience's Goodwill & Intangibles fell 3904.3% to $308060.0 in Q4 2025 from the same period last year, while for Nov 2025 it was $308060.0, marking a year-over-year decrease of 3904.3%. This contributed to the annual value of $75106.0 for FY2025, which is 8546.36% down from last year.
  • As of Q4 2025, Lexaria Bioscience's Goodwill & Intangibles stood at $308060.0, which was down 3904.3% from $75106.0 recorded in Q3 2025.
  • Lexaria Bioscience's Goodwill & Intangibles' 5-year high stood at $519253.0 during Q1 2024, with a 5-year trough of $33778.0 in Q1 2023.
  • Its 5-year average for Goodwill & Intangibles is $277028.0, with a median of $303554.5 in 2021.
  • Its Goodwill & Intangibles has fluctuated over the past 5 years, first surged by 143725.21% in 2024, then plummeted by 9209.4% in 2025.
  • Over the past 5 years, Lexaria Bioscience's Goodwill & Intangibles (Quarter) stood at $378746.0 in 2021, then surged by 32.16% to $500549.0 in 2022, then decreased by 1.23% to $494377.0 in 2023, then grew by 2.22% to $505373.0 in 2024, then tumbled by 39.04% to $308060.0 in 2025.
  • Its Goodwill & Intangibles was $308060.0 in Q4 2025, compared to $75106.0 in Q3 2025 and $60496.0 in Q2 2025.